References
- Chien YW. Novel drug delivery system. 2nd ed, revised and expanded. New York: Marcel Dekker, inc.; 1992:269–300.
- Mathiowitz E. Encyclopedia of controlled drug delivery. Vol. 2. New York: John Wiley & sons, Inc. 1999:605–626.
- Sultana Y, Aquil M, Ali A. Ocular insert for controlled delivery of pefloxacin mesylate: preparation and evaluation. Acta Pharma 2005;55:305–314.
- Ostergaard C, Sorensen JD, Moller NF. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits. Antimicrob Agents Chemother 1998;42:1706–1712.
- Blondeau JM. Fluoroquinolones: Mechanism of action, classification, and development of resistance. Surv Ophthalmol 2004;(suppl. 2):S73–78.
- Price MO, Price FW Jr, Maclellan D Effect of gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions on human corneal epithelium following 2 dosing regimens. J Cataract Refract Surg. 2005; 31:2137–2141.
- Karatas A, Baykara T. Studies on indomethacin insert prepared by water soluble polymers: The relation between dissolution rate and swelling behavior. Il Farmaco 2001;56:197–202.
- Sreenivas SA, Hiremanth SP, Godbole AM. Ofloxacin ocular inserts: Design, formulation and evaluation. IJPT 2006;5:159–162.
- Saisivam S, Muthumanikandar RV, Nagarajan M. Design and evaluation of ciprofloxacin HCl ocuserts. Indian J Pharma Sci 1999;61:34–38.
- Manvi FV, Soppimath KS, Gadad AP. Development and evaluation of timolol maleate ocular inserts. Indian Drugs 1997;34:264–268.
- Khan S, Ali A, Singhavi D, Pramod Y. Controlled ocular delivery of acyclovir trough rate controlling ocular insert of eudragit: A technical note. AAPS PharmSciTech 2008;9:169–172.
- Vijayendra SM, Nanjawade BK, Manvi FV. Development of sustained ocular drug delivery system for betaxolol. Indian J Pharm Educ Res 2006;40:165–168.
- Venugopal K, Saha RN. New, simple and validated UV-spectrophotometric method for the estimation of Gatifloxacin in bulk and formulations. Il Farmaco 2005;60:906–912.
- Harishkumar SL, Balasubramaniaum J, Kumar MT. In vitro characterization of physically reinforced ocular inserts of Indomethacin. Acta Pharmaceutica Turcica 2004;46:17–24.
- Ubaidulla U, Reddy MV, Ruckmani K. Transdermal therapeutic system of carvedilol: Effect of hydrophilic and hydrophobic matric on in vitro and in vivo characteristics. AAPS PharmSciTech 2007;8:E1–8.
- Dhanaraju MD, Sivakumar VR, Bhaskar K. Bioadhesive ocuserts matrix for ophthalmic administration of ciprofloxacin HCl. Indian Drugs 2002;39:222–224.
- Mundada AS, Shrikhande BK. Design and evaluation of soluble ophthalmic insert for controlled release of ciprofloxacin hydrochloride. Drug Dev Ind Pharm 2006;32:443–448.
- Patel U, Chaudhary KA, Chotai NP, Chirag N. Formulation and evaluation of indomethacin ophthalmic inserts. Indian J Pharm Educ Res 2008;42:348–352.
- Mishra DN, Gilhotra RM. Development studies on gel-forming erodible ocular polymeric films of Gatifloxacin sesquehydrate. Acta Pharmaceut Sci 2008;50:145–152.
- Mundada A, Shrikhande BK. Formulation and evaluation of ciprofloxacin hydrochloride soluble ocular insert. Current Eye Res 2008;33:469–475.
- Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharmaceut Sci 2001;13:123–133.
- Charoo NA, Kohli K, Ali A, Anwer A. Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: In vitro and in vivo studies. Drug Dev Ind Pharm 2003;29:215–221.
- OECD guideline (2002). Acute eye irritation/corrosion, test guideline 405.